Presence of Signs of Central Sensitization in Episodic and Chronic Migraine
NCT05162664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2023-11-18
Summary
Nowadays migraine is conceptualized as a continuum, with at the one hand episodic migraine (EM) and at the other hand chronic migraine (CM) (1). The general aim of the study is to determine where exactly in this continuum central sensitization (CS) appears.
Recent studies support the presence of CS in migraine patients (2,3), but controversial evidence exists about where in the continuum exactly CS appears. Some studies determined no differences in sings of CS between EM and CM (4,5), whether other research indicate a clear difference between EM and CM (6-8). However a significant difference in CS parameters could be determined between a patient group (EM or CM) and a healthy control group (3,4,8). In addition, CS appears to be present during the migraine attack (2). In this research, the presence of signs of CS will be determined in between headache phases.
The primary outcome measure is identification of CS by PPT, QST, TS, CPM and CSI. Secondary outcome measures are the outcome of the MIDAS, HADS and EUROLIGHT.
Conditions
- Central Sensitisation
- Migraine
Interventions
- OTHER
-
Pressure pain thresholds
PPT will be performed firstly at the anterior tibial muscle halfway between the most superior attachment to the tibia and its tendon in the upper one third of the muscle belly (13) and secondly at the middle of the temporalis muscle (12), using a digital algometer (Wagner FPX 50) with a 1 cm2 rubber tip. The pressure algometer will apply a perpendicular increasing pressure (1kg/s) at the different test locations until the participant reports the first feeling of pain. The PPT of 4 series of ascending stimulus intensities, with an inter-stimulus interval (ISI) of 20sec between the different stimuli and an ISI of 60sec between the 2 locations, will be measured. The first stimulus is a familiarization stimulus. Afterwards the mean of the 3 subsequent stimuli will be calculated.
- OTHER
-
Thermal detection and pain thresholds
The thermal tests will be performed unilateral at tibial anterior, thenar and the forehead, using a TSA-2 (Neuro Sensory Analyzer, MEDOC). At first cold and heat detection thresholds will be measured. The patient will be asked to indicate when they feel a change in temperature. Afterwards the patient will be asked to indicate when the stimulus becomes painful to determine the cold and heat pain thresholds. The thresholds of 4 series of stimuli will be measured. The first stimulus is a familiarization stimulus. Afterwards the mean of the 3 subsequent stimuli will be calculated for every location. The subject will push a button when the thresholds are reached. The baseline temperature will be 32°C and the stimuli will increase with 1°C/s (14).
- OTHER
-
Temporal summation
The temporal summation will be assessed at the thenar eminence (19,20) using a ramp and hold protocol with the TSA-2 (Neuro Sensory Analyzer, MEDOC). Heat stimuli will be applied for a duration of 15sec. The stimulus temperature will increase from a baseline temperature of 35°C for 9sec at a sensitivity-adjusted rate of about 1,5°C/s until the HTP 5/10 of the thenar is reached. Afterwards the temperature will remain steady for the next 6 seconds. The maximal pain rating should be 50 ± 10 NRS. Subjects rate the pain intensity at the end of the ramp (9sec) and at the end of the hold procedure (15sec) using the NRS. Afterwards the ramp and hold aftersensations are measured. The subjects have to rate the pain intensity every 5sec for 30sec after the termination of the heat stimulus.
- OTHER
-
Conditioned pain modulation
CPM will be assessed by comparing heat pain thresholds and pressure pain thresholds before and after giving a conditioning stimulus at a pain free distant zone by using a second thermode of the TSA-2 (17). The conditioning stimulus (HPT 4/10 (18) at the TA) will be applied for 120 seconds. The first test stimulus will be applied at the forehead 30 seconds after the start of the conditioning stimulus (17). The HPT will be measured twice with an ISI of 20 seconds. Immediately after the end of the application of the conditioning stimulus (120 seconds), the HPT at the forehead will be measured again twice, with an ISI of 20 seconds. Afterwards, there will be 10 minutes of rest to avoid bias.
Sponsors & Collaborators
-
University Ghent
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-15
- Primary Completion
- 2022-08-01
- Completion
- 2022-10-01
Countries
- Belgium
Study Locations
More Related Trials
-
Integrated Care for Migraine and Chronic Tension-type Headaches
NCT03503734 ·Status: COMPLETED
-
Manageable Environmental Factors in Migraine
NCT06304675 ·Status: COMPLETED
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NCT06167655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine
NCT04361721 ·Status: UNKNOWN
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
Headache in Undergraduate Students and Biopsychosocial Status
NCT05843760 ·Status: COMPLETED
-
Nutritional Intervention in Migraine
NCT02703129 ·Status: COMPLETED ·Phase: NA
-
Pain Control in Episodic and Chronic Migraine
NCT06599905 ·Status: COMPLETED ·Phase: NA
-
Pain Processing in Adults With Migraines
NCT02748577 ·Status: COMPLETED ·Phase: NA
-
Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?
NCT00880425 ·Status: COMPLETED
-
Rate , Predictors and Outcome of Chronic Migraine
NCT05079659 ·Status: UNKNOWN
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks
NCT02583581 ·Status: UNKNOWN ·Phase: NA
-
Occipital Transcutaneous Stimulation in Chronic Migraine
NCT02307071 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
Observational Study to Assess Migraine Prediction Tool
NCT05523310 ·Status: SUSPENDED
-
Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
NCT03772860 ·Status: UNKNOWN
-
Familial and Environmental Factors Behind Migraine
NCT04356079 ·Status: UNKNOWN
-
mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache
NCT04983186 ·Status: COMPLETED ·Phase: NA
-
Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine
NCT01851148 ·Status: COMPLETED ·Phase: NA
-
Mindfulness Therapy for Chronic Migraine
NCT03671681 ·Status: COMPLETED ·Phase: PHASE4
-
Migraine and Endothelial Dysfunction
NCT01388699 ·Status: COMPLETED
-
Non-pharmacological Treatments in Migraine.
NCT05596058 ·Status: TERMINATED ·Phase: NA
-
Prevalence and Determinants of Migraine Among Headache Patients
NCT07038499 ·Status: NOT_YET_RECRUITING
-
Mindfulness and Mechanisms of Pain Processing in Adults With Migraines
NCT02695498 ·Status: COMPLETED ·Phase: NA